XMTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Xometry Inc (XMTR) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown strong revenue growth and has potential in the on-demand manufacturing market, the stock is currently facing bearish technical indicators, leadership transition concerns, and mixed sentiment from analysts. Given the user's impatience and unwillingness to wait for optimal entry points, it is better to hold off on investing in XMTR until clearer positive signals emerge.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 45.464, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 40, with key support at 36.825 and resistance at 43.174. Overall, the technical indicators suggest a bearish trend.
G2 Investment Partners acquired a significant stake in Xometry, reflecting institutional confidence.
Strong Q4 2025 revenue growth of 29.52% YoY and adjusted EBITDA break-even.
The stock has gained 50.9% over the past year, showcasing potential in the on-demand manufacturing market.
CEO transition and concerns about leadership stability.
Deceleration in 2026 marketplace revenue growth as per guidance.
Mixed analyst sentiment with lowered price targets and uncertainty around AI concerns in public markets.
Pre-market price drop of -1.48%, reflecting weak short-term sentiment.
In Q4 2025, revenue increased by 29.52% YoY to $192.4 million, but net income dropped to -$8.63 million (-12.69% YoY), and EPS declined by 15% to -0.17. Gross margin also fell slightly to 39.11% (-1.56% YoY). While revenue growth is strong, profitability remains a concern.
Analysts have mixed views: RBC Capital, Wedbush, and Citi lowered their price targets, citing leadership concerns and market uncertainty, but Wedbush and William Blair maintain Outperform ratings, recommending buying on weakness. UBS raised its price target slightly but remains Neutral on the stock.
